Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Feb 1;316(2):H260-H261.
doi: 10.1152/ajpheart.00736.2018. Epub 2018 Nov 21.

A step closer to improving cardiac homing of adipose-derived mesenchymal stem cells

Amanda J LeBlanc  1   2 , Shizuka Uchida  1   3
Affiliations
Editorial

A step closer to improving cardiac homing of adipose-derived mesenchymal stem cells

Amanda J LeBlanc et al. Am J Physiol Heart Circ Physiol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest, financial or otherwise, are declared by the authors.

Figures

Fig. 1.
Fig. 1.
Cell therapy for cardiac repair. A: current understanding of cell therapy. To date, various sources of cells have been injected into animals to test the efficacies of cell therapy. Among the proposed mechanisms of action, the most probable mechanism is of paracrine effects of the injected cells. To improve the beneficial effects of cell therapy, various methods have been proposed and tested. B: resistin treatment improves the beneficial effects of adipose-derived mesenchymal stem cells (ADSCs) via the matrix metalloproteinase (MMP)-9-ERK pathway. LVEF, left ventricular ejection fraction.
See this image and copyright information in PMC

Comment on

References

    1. Banerjee MN, Bolli R, Hare JM. Clinical studies of cell therapy in cardiovascular medicine: recent developments and future directions. Circ Res 123: 266–287, 2018. doi:10.1161/CIRCRESAHA.118.311217. - DOI - PMC - PubMed
    1. Bulluck H, Yellon DM, Hausenloy DJ. Reducing myocardial infarct size: challenges and future opportunities. Heart 102: 341–348, 2016. doi:10.1136/heartjnl-2015-307855. - DOI - PMC - PubMed
    1. Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation 128: 388–400, 2013. doi:10.1161/CIRCULATIONAHA.113.001878. - DOI - PMC - PubMed
    1. He Y, Guo Y, Xia Y, Guo Y, Wang R, Zhang F, Guo L, Liu Y, Yin T, Gao C, Gao E, Li C, Wang S, Zhang L, Yan W, Tao L. Resistin promotes cardiac homing of mesenchymal stem cells and functional recovery after myocardial ischemia/reperfusion via the ERK1/2-MMP-9 pathway. Am J Physiol Heart Circ Physiol 316: H233–H244, 2019. doi:10.1152/ajpheart.00457.2018. - DOI - PubMed
    1. Jamaluddin MS, Weakley SM, Yao Q, Chen C. Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 165: 622–632, 2012. doi:10.1111/j.1476-5381.2011.01369.x. - DOI - PMC - PubMed

LinkOut - more resources